MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

MeiraGTx Holdings plc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$9.45+0.17 (+1.83%)

Close on Oct 19, 2026

Market cap: $886.46M
P/E (TTM): 13.3
Dividend yield: –

MeiraGTx Holdings plc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Revenue	81	33	14	16	38	16	13	–	–
Research & Development	130	119	104	86	67	34	25	34	22
Selling, General & Admin	58	78	–	–	–	–	–	–	–
Selling & Marketing	4.84	24	–	–	–	–	–	–	–
General & Administrative	53	54	47	47	44	44	47	44	9.33
Operating Expenses	187	197	151	132	110	78	72	78	32
Operating Income	-106	-164	-137	-116	-73	-63	-58	-78	-32
Interest Expense	12	13	13	4.95	0.29	0.14	0.05	0.03	0.04
Interest & Investment Income	1.82	4.15	2.27	0.78	0.21	1.28	0.37	0.05	0.03
Asset Impairment Charges	–	–	–	–	0	0	0	0	0
Gain (Loss) on Sale of Assets	-0.36	-0.01	–	–	-0.06	-0.21	–	–	–
Pretax Income	-114	-148	-84	-130	-80	-58	-55	-83	-31
Income Tax Expense	0	0	0	–	0	0	0	-0.47	0
Net Income incl. Noncontrolling Interests	-114	-148	-84	-130	-80	-58	-55	-83	-31
Net Income	-114	-148	-84	-130	-80	-58	-55	-83	-31
Net Income to Common	-114	-148	-84	-130	-80	-58	-55	-85	-32
EPS (Basic)(per share)	-1.42	-2.12	-1.49	-2.87	-1.80	-1.54	-1.65	-4.47	-3.72
EPS (Diluted)(per share)	-1.42	-2.12	-1.49	-2.87	-1.80	-1.54	-1.65	-4.47	-3.72
Shares Outstanding (Basic, Weighted)(shares)	80	70	56	45	44	38	33	19	8.57
Shares Outstanding (Diluted, Weighted)(shares)	80	70	56	45	44	38	33	19	8.57
EBITDA	-93	-151	-123	-108	-65	-58	-56	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 46.3%
Net margin: 19.9%
Return on equity, FY2025: -368.2%

Financial strength

Current ratio: 3.76
Debt to equity: –
Debt to assets: 25.2%
Cash to current liabilities: 246.4%

Valuation

P/E ratio: 13.3
Price to sales: 2.23
Price to book: –
Dividend yield: –